BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 2


Figure 2. Pharmacokinetics of gold nanoparticles(a–d) and iodine contrast agent (e–h, Omnipaque®) in mice. (a,e) Before injection. (b,f) 2 min after injection; (c,g) 10 min after injection; (d,h) 60 min after injection. The gold nanoparticles show low liver and spleen uptake and clearance via kidneys and bladder (b–d). At 60 min (d), the contrast in the gold-injected mouse is similar to the uninjected mouse (a), indicating efficient clearance.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS